| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | complement component C3b binding | 3.34e-08 | 12 | 59 | 4 | GO:0001851 | |
| GeneOntologyMolecularFunction | opsonin binding | 8.30e-07 | 25 | 59 | 4 | GO:0001846 | |
| GeneOntologyMolecularFunction | complement binding | 2.32e-06 | 32 | 59 | 4 | GO:0001848 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 8.48e-05 | 29 | 59 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.77e-04 | 37 | 59 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 4.61e-04 | 51 | 59 | 3 | GO:0043394 | |
| GeneOntologyBiologicalProcess | complement activation | 4.32e-08 | 70 | 58 | 6 | GO:0006956 | |
| GeneOntologyBiologicalProcess | regulation of complement activation | 9.41e-07 | 27 | 58 | 4 | GO:0030449 | |
| GeneOntologyBiologicalProcess | sensory organ development | 5.05e-06 | 730 | 58 | 11 | GO:0007423 | |
| GeneOntologyBiologicalProcess | regulation of complement-dependent cytotoxicity | 5.92e-06 | 13 | 58 | 3 | GO:1903659 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 8.42e-06 | 171 | 58 | 6 | GO:0048593 | |
| GeneOntologyBiologicalProcess | complement-dependent cytotoxicity | 1.15e-05 | 16 | 58 | 3 | GO:0097278 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 2.29e-05 | 204 | 58 | 6 | GO:0048592 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 2.41e-05 | 426 | 58 | 8 | GO:0043010 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response | 2.44e-05 | 60 | 58 | 4 | GO:0002920 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 4.80e-05 | 343 | 58 | 7 | GO:0090596 | |
| GeneOntologyBiologicalProcess | eye development | 5.60e-05 | 480 | 58 | 8 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 5.85e-05 | 483 | 58 | 8 | GO:0150063 | |
| GeneOntologyBiologicalProcess | sensory system development | 6.57e-05 | 491 | 58 | 8 | GO:0048880 | |
| GeneOntologyBiologicalProcess | activation of membrane attack complex | 1.16e-04 | 6 | 58 | 2 | GO:0001905 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, alternative pathway | 1.62e-04 | 7 | 58 | 2 | GO:0030451 | |
| GeneOntologyBiologicalProcess | inflammatory response to wounding | 1.66e-04 | 38 | 58 | 3 | GO:0090594 | |
| GeneOntologyBiologicalProcess | neural retina development | 1.95e-04 | 102 | 58 | 4 | GO:0003407 | |
| GeneOntologyBiologicalProcess | monocyte aggregation | 2.76e-04 | 9 | 58 | 2 | GO:0070487 | |
| GeneOntologyBiologicalProcess | immune complex clearance | 2.76e-04 | 9 | 58 | 2 | GO:0002434 | |
| GeneOntologyBiologicalProcess | humoral immune response | 2.78e-04 | 321 | 58 | 6 | GO:0006959 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 3.45e-04 | 10 | 58 | 2 | GO:0030450 | |
| GeneOntologyBiologicalProcess | retinal pigment epithelium development | 3.45e-04 | 10 | 58 | 2 | GO:0003406 | |
| GeneOntologyBiologicalProcess | camera-type eye photoreceptor cell differentiation | 3.55e-04 | 49 | 58 | 3 | GO:0060219 | |
| GeneOntologyBiologicalProcess | eye photoreceptor cell development | 4.23e-04 | 52 | 58 | 3 | GO:0042462 | |
| GeneOntologyBiologicalProcess | organ or tissue specific immune response | 4.73e-04 | 54 | 58 | 3 | GO:0002251 | |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | 5.16e-04 | 235 | 58 | 5 | GO:0016064 | |
| GeneOntologyBiologicalProcess | kidney development | 6.07e-04 | 372 | 58 | 6 | GO:0001822 | |
| GeneOntologyBiologicalProcess | B cell mediated immunity | 6.11e-04 | 244 | 58 | 5 | GO:0019724 | |
| GeneOntologyBiologicalProcess | activin receptor signaling pathway | 6.44e-04 | 60 | 58 | 3 | GO:0032924 | |
| GeneOntologyBiologicalProcess | female pregnancy | 6.70e-04 | 249 | 58 | 5 | GO:0007565 | |
| GeneOntologyBiologicalProcess | epithelium development | CFH MYF6 JAG1 PAX4 ARID1A CDH1 GDF11 IQGAP3 S1PR3 CRB2 SMAD3 CFHR4 | 6.75e-04 | 1469 | 58 | 12 | GO:0060429 |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 6.92e-04 | 14 | 58 | 2 | GO:0045916 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 7.02e-04 | 875 | 58 | 9 | GO:0045596 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 7.18e-04 | 1269 | 58 | 11 | GO:0009887 | |
| GeneOntologyBiologicalProcess | renal system development | 7.36e-04 | 386 | 58 | 6 | GO:0072001 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial to mesenchymal transition | 7.43e-04 | 63 | 58 | 3 | GO:0010718 | |
| GeneOntologyBiologicalProcess | negative regulation of endothelial cell differentiation | 7.97e-04 | 15 | 58 | 2 | GO:0045602 | |
| GeneOntologyBiologicalProcess | regulation of immune response | 8.10e-04 | 1085 | 58 | 10 | GO:0050776 | |
| GeneOntologyBiologicalProcess | retinal rod cell development | 1.03e-03 | 17 | 58 | 2 | GO:0046548 | |
| GeneOntologyBiologicalProcess | endocrine system development | 1.09e-03 | 161 | 58 | 4 | GO:0035270 | |
| GeneOntologyBiologicalProcess | eye photoreceptor cell differentiation | 1.10e-03 | 72 | 58 | 3 | GO:0001754 | |
| GeneOntologyBiologicalProcess | photoreceptor cell development | 1.14e-03 | 73 | 58 | 3 | GO:0042461 | |
| GeneOntologyBiologicalProcess | columnar/cuboidal epithelial cell differentiation | 1.17e-03 | 164 | 58 | 4 | GO:0002065 | |
| GeneOntologyBiologicalProcess | somitogenesis | 1.28e-03 | 76 | 58 | 3 | GO:0001756 | |
| GeneOntologyBiologicalProcess | leukocyte aggregation | 1.29e-03 | 19 | 58 | 2 | GO:0070486 | |
| GeneOntologyBiologicalProcess | complement activation, alternative pathway | 1.29e-03 | 19 | 58 | 2 | GO:0006957 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 1.29e-03 | 19 | 58 | 2 | GO:0002921 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 1.32e-03 | 290 | 58 | 5 | GO:0044703 | |
| GeneOntologyBiologicalProcess | glomerulus development | 1.33e-03 | 77 | 58 | 3 | GO:0032835 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 1.41e-03 | 294 | 58 | 5 | GO:0044706 | |
| GeneOntologyBiologicalProcess | polyamine metabolic process | 1.43e-03 | 20 | 58 | 2 | GO:0006595 | |
| GeneOntologyBiologicalProcess | regulation of B cell mediated immunity | 1.43e-03 | 79 | 58 | 3 | GO:0002712 | |
| GeneOntologyBiologicalProcess | regulation of immunoglobulin mediated immune response | 1.43e-03 | 79 | 58 | 3 | GO:0002889 | |
| GeneOntologyBiologicalProcess | nephron development | 1.46e-03 | 174 | 58 | 4 | GO:0072006 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 1.60e-03 | 449 | 58 | 6 | GO:0002449 | |
| GeneOntologyCellularComponent | symbiont cell surface | 2.17e-04 | 8 | 59 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 2.78e-04 | 9 | 59 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | flotillin complex | 3.47e-04 | 10 | 59 | 2 | GO:0016600 | |
| HumanPheno | Decreased circulating complement factor H concentration | 1.48e-07 | 4 | 18 | 3 | HP:0005369 | |
| HumanPheno | Decreased circulating complement factor I concentration | 3.69e-07 | 5 | 18 | 3 | HP:0005356 | |
| HumanPheno | Decreased circulating complement factor B concentration | 3.69e-07 | 5 | 18 | 3 | HP:0005416 | |
| HumanPheno | Macular hemorrhage | 1.29e-06 | 7 | 18 | 3 | HP:0025574 | |
| HumanPheno | Macular drusen | 2.05e-06 | 8 | 18 | 3 | HP:0030499 | |
| HumanPheno | Anuria | 1.04e-05 | 13 | 18 | 3 | HP:0100519 | |
| HumanPheno | Schistocytosis | 1.04e-05 | 13 | 18 | 3 | HP:0001981 | |
| HumanPheno | Microangiopathic hemolytic anemia | 1.32e-05 | 14 | 18 | 3 | HP:0001937 | |
| HumanPheno | Hemolytic-uremic syndrome | 2.44e-05 | 17 | 18 | 3 | HP:0005575 | |
| HumanPheno | Yellow/white lesions of the macula | 3.47e-05 | 19 | 18 | 3 | HP:0030500 | |
| HumanPheno | Increased blood urea nitrogen | 6.28e-05 | 23 | 18 | 3 | HP:0003138 | |
| HumanPheno | Choroidal neovascularization | 6.28e-05 | 23 | 18 | 3 | HP:0011506 | |
| HumanPheno | Foveal hypopigmentation | 7.05e-05 | 4 | 18 | 2 | HP:0012643 | |
| HumanPheno | Abnormal blood urea nitrogen concentration | 8.12e-05 | 25 | 18 | 3 | HP:0031970 | |
| HumanPheno | Abnormal urine output | 8.18e-05 | 69 | 18 | 4 | HP:0012590 | |
| HumanPheno | Abnormality of renal excretion | 1.13e-04 | 75 | 18 | 4 | HP:0011036 | |
| HumanPheno | Abnormal morphology of the choroidal vasculature | 1.15e-04 | 28 | 18 | 3 | HP:0025568 | |
| HumanPheno | Drusen | 1.28e-04 | 29 | 18 | 3 | HP:0011510 | |
| HumanPheno | Fundus hemorrhage | 1.42e-04 | 30 | 18 | 3 | HP:0031803 | |
| HumanPheno | Decreased urine output | 1.42e-04 | 30 | 18 | 3 | HP:0011037 | |
| HumanPheno | Retinal hemorrhage | 1.42e-04 | 30 | 18 | 3 | HP:0000573 | |
| HumanPheno | Geographic atrophy | 2.45e-04 | 7 | 18 | 2 | HP:0031609 | |
| HumanPheno | Clubbing of fingers | 3.13e-04 | 39 | 18 | 3 | HP:0100759 | |
| HumanPheno | Abnormality of foveal pigmentation | 3.26e-04 | 8 | 18 | 2 | HP:0030493 | |
| HumanPheno | Decreased circulating complement C3 concentration | 4.19e-04 | 43 | 18 | 3 | HP:0005421 | |
| HumanPheno | Acute kidney injury | 4.48e-04 | 44 | 18 | 3 | HP:0001919 | |
| HumanPheno | Reticulocytosis | 5.45e-04 | 47 | 18 | 3 | HP:0001923 | |
| HumanPheno | Abnormality of macular pigmentation | 5.45e-04 | 47 | 18 | 3 | HP:0008002 | |
| HumanPheno | Elevated circulating creatinine concentration | 7.35e-04 | 52 | 18 | 3 | HP:0003259 | |
| HumanPheno | Hemorrhage of the eye | 7.77e-04 | 53 | 18 | 3 | HP:0011885 | |
| MousePheno | white pupil | 1.01e-05 | 2 | 45 | 2 | MP:0006242 | |
| MousePheno | decreased serum complement activity | 1.01e-05 | 2 | 45 | 2 | MP:0012553 | |
| MousePheno | artery occlusion | 1.01e-05 | 2 | 45 | 2 | MP:0006134 | |
| MousePheno | decreased complement C5 level | 1.01e-05 | 2 | 45 | 2 | MP:0012609 | |
| MousePheno | abnormal complement C5 level | 1.01e-05 | 2 | 45 | 2 | MP:0012608 | |
| MousePheno | abnormal hepatic portal vein thrombosis | 1.01e-05 | 2 | 45 | 2 | MP:0031159 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 1.16e-05 | 44 | 45 | 4 | MP:0011348 | |
| MousePheno | increased susceptilbility to retina ischemic injury | 3.03e-05 | 3 | 45 | 2 | MP:0012049 | |
| MousePheno | abnormal kidney venous thrombosis | 3.03e-05 | 3 | 45 | 2 | MP:0031161 | |
| MousePheno | abnormal response to retina ischemic injury | 6.05e-05 | 4 | 45 | 2 | MP:0012048 | |
| MousePheno | increased susceptibility to type III hypersensitivity reaction | 6.05e-05 | 4 | 45 | 2 | MP:0005615 | |
| MousePheno | decreased circulating complement protein level | 6.05e-05 | 4 | 45 | 2 | MP:0020216 | |
| MousePheno | mesangial cell interposition | 6.05e-05 | 4 | 45 | 2 | MP:0011512 | |
| MousePheno | abnormal brain thrombosis | 6.05e-05 | 4 | 45 | 2 | MP:0031168 | |
| MousePheno | increased creatine level | 6.05e-05 | 4 | 45 | 2 | MP:0010061 | |
| MousePheno | abnormal complement pathway | 7.70e-05 | 26 | 45 | 3 | MP:0002471 | |
| MousePheno | abnormal venous thrombosis | 1.01e-04 | 5 | 45 | 2 | MP:0031158 | |
| MousePheno | abnormal lung thrombosis | 1.01e-04 | 5 | 45 | 2 | MP:0031167 | |
| MousePheno | abnormal circulating complement protein level | 1.51e-04 | 6 | 45 | 2 | MP:0010215 | |
| MousePheno | abnormal glomerular capillary thrombosis | 2.11e-04 | 7 | 45 | 2 | MP:0011508 | |
| MousePheno | brain ischemia | 2.80e-04 | 8 | 45 | 2 | MP:0006080 | |
| MousePheno | abnormal complement protein level | 3.60e-04 | 9 | 45 | 2 | MP:0011566 | |
| MousePheno | abnormal creatine level | 3.60e-04 | 9 | 45 | 2 | MP:0010060 | |
| MousePheno | abnormal type III hypersensitivity reaction | 4.49e-04 | 10 | 45 | 2 | MP:0002533 | |
| MousePheno | abnormal kidney thrombosis | 4.49e-04 | 10 | 45 | 2 | MP:0011507 | |
| MousePheno | abnormal glomerular capillary morphology | 4.58e-04 | 47 | 45 | 3 | MP:0011320 | |
| MousePheno | abnormal kidney capillary morphology | 4.87e-04 | 48 | 45 | 3 | MP:0011310 | |
| MousePheno | abnormal mesangial matrix morphology | 5.83e-04 | 51 | 45 | 3 | MP:0011338 | |
| MousePheno | abnormal synovial joint morphology | 6.63e-04 | 124 | 45 | 4 | MP:0030804 | |
| MousePheno | abnormal visual acuity | 7.73e-04 | 13 | 45 | 2 | MP:0011832 | |
| MousePheno | decreased visual acuity | 7.73e-04 | 13 | 45 | 2 | MP:0006149 | |
| MousePheno | abnormal articular cartilage morphology | 9.00e-04 | 14 | 45 | 2 | MP:0006433 | |
| MousePheno | abnormal Bruch membrane morphology | 9.00e-04 | 14 | 45 | 2 | MP:0005239 | |
| MousePheno | retina detachment | 1.04e-03 | 15 | 45 | 2 | MP:0003099 | |
| MousePheno | albuminuria | 1.08e-03 | 63 | 45 | 3 | MP:0002871 | |
| MousePheno | abnormal placenta morphology | 1.33e-03 | 525 | 45 | 7 | MP:0001711 | |
| MousePheno | amyloid beta deposits | 1.34e-03 | 17 | 45 | 2 | MP:0003329 | |
| MousePheno | abnormal rib morphology | 1.35e-03 | 257 | 45 | 5 | MP:0000150 | |
| Domain | Sushi | 9.03e-09 | 52 | 55 | 6 | PF00084 | |
| Domain | CCP | 1.14e-08 | 54 | 55 | 6 | SM00032 | |
| Domain | SUSHI | 1.43e-08 | 56 | 55 | 6 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.59e-08 | 57 | 55 | 6 | IPR000436 | |
| Domain | Keratin_matx | 2.55e-05 | 3 | 55 | 2 | PF04579 | |
| Domain | Keratin_matx | 5.09e-05 | 4 | 55 | 2 | PD010562 | |
| Domain | hEGF | 7.51e-05 | 28 | 55 | 3 | PF12661 | |
| Domain | Keratin_matx | 8.47e-05 | 5 | 55 | 2 | IPR007659 | |
| Domain | EGF | 5.16e-04 | 126 | 55 | 4 | PF00008 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 4.76e-10 | 6 | 35 | 4 | M47880 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 3.46e-07 | 115 | 35 | 6 | M19752 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 5.34e-05 | 84 | 35 | 4 | MM14653 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ALTERNATIVE_PATHWAY_OF_COMPLEMENT_CASCADE_C3B_BREAKDOWN | 5.96e-05 | 5 | 35 | 2 | M47875 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 1.32e-04 | 106 | 35 | 4 | M42535 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 2.39e-04 | 49 | 35 | 3 | M48250 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.84e-04 | 140 | 35 | 4 | M587 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 6.57e-04 | 69 | 35 | 3 | M16894 | |
| Pathway | WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER | 7.03e-04 | 16 | 35 | 2 | M39472 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 7.96e-04 | 17 | 35 | 2 | MM1509 | |
| Pathway | REACTOME_FORMATION_OF_DEFINITIVE_ENDODERM | 7.96e-04 | 17 | 35 | 2 | M48030 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.12e-04 | 300 | 35 | 5 | M610 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 9.97e-04 | 19 | 35 | 2 | M39370 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 9.97e-04 | 19 | 35 | 2 | M18933 | |
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 36793547 | ||
| Pubmed | Identification and sequence analysis of four complement factor H-related transcripts in mouse liver. | 3.73e-11 | 5 | 59 | 4 | 1689298 | |
| Pubmed | A radiation hybrid map of complement factor H and factor H-related genes. | 3.73e-11 | 5 | 59 | 4 | 10380701 | |
| Pubmed | 1.12e-10 | 6 | 59 | 4 | 27196323 | ||
| Pubmed | 1.12e-10 | 6 | 59 | 4 | 17438673 | ||
| Pubmed | 2.60e-10 | 7 | 59 | 4 | 19861685 | ||
| Pubmed | 9.35e-10 | 9 | 59 | 4 | 20059470 | ||
| Pubmed | FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation. | 9.35e-10 | 9 | 59 | 4 | 28533443 | |
| Pubmed | 2.44e-09 | 11 | 59 | 4 | 20301541 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 10781834 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 25205734 | ||
| Pubmed | Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. | 4.64e-09 | 3 | 59 | 3 | 18006700 | |
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 26942649 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 20843825 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 32321835 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 21637784 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 20581873 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 26163426 | ||
| Pubmed | Association assessment of copy number polymorphism and risk of age-related macular degeneration. | 4.64e-09 | 3 | 59 | 3 | 21856016 | |
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 19531976 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 22848687 | ||
| Pubmed | Two factor H-related proteins from the mouse: expression analysis and functional characterization. | 4.64e-09 | 3 | 59 | 3 | 17028856 | |
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 25684976 | ||
| Pubmed | 1.85e-08 | 4 | 59 | 3 | 24333077 | ||
| Pubmed | Genome-wide association study identifies susceptibility loci for IgA nephropathy. | 2.84e-08 | 19 | 59 | 4 | 21399633 | |
| Pubmed | Factor H-related proteins determine complement-activating surfaces. | 4.63e-08 | 5 | 59 | 3 | 25979655 | |
| Pubmed | Complement factor H and related proteins: an expanding family of complement-regulatory proteins? | 4.63e-08 | 5 | 59 | 3 | 8172644 | |
| Pubmed | 4.63e-08 | 5 | 59 | 3 | 20042240 | ||
| Pubmed | Dimerization of complement factor H-related proteins modulates complement activation in vivo. | 9.24e-08 | 6 | 59 | 3 | 23487775 | |
| Pubmed | 9.24e-08 | 6 | 59 | 3 | 24557084 | ||
| Pubmed | Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation. | 1.62e-07 | 7 | 59 | 3 | 28057640 | |
| Pubmed | The regulation of the complement system: insights from genetically-engineered mice. | 1.62e-07 | 7 | 59 | 3 | 12914820 | |
| Pubmed | Risk of non-Hodgkin lymphoma in association with germline variation in complement genes. | 2.27e-07 | 31 | 59 | 4 | 19344414 | |
| Pubmed | 3.87e-07 | 9 | 59 | 3 | 18947875 | ||
| Pubmed | Circulating AIM prevents hepatocellular carcinoma through complement activation. | 5.52e-07 | 10 | 59 | 3 | 25284781 | |
| Pubmed | Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. | 7.58e-07 | 11 | 59 | 3 | 23204401 | |
| Pubmed | Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis. | 1.67e-06 | 14 | 59 | 3 | 19299737 | |
| Pubmed | 1.67e-06 | 14 | 59 | 3 | 33159885 | ||
| Pubmed | Genetic influences on the end-stage effector phase of arthritis. | 2.56e-06 | 16 | 59 | 3 | 11489951 | |
| Pubmed | 2.56e-06 | 16 | 59 | 3 | 17021047 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 29114042 | ||
| Pubmed | Absence of complement factor H reduces physical performance in C57BL6 mice. | 2.83e-06 | 2 | 59 | 2 | 32962822 | |
| Pubmed | Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings. | 2.83e-06 | 2 | 59 | 2 | 20538999 | |
| Pubmed | Inheritance, hormonal regulation and properties of polymorphic murine antigens Mud1 and Mud2. | 2.83e-06 | 2 | 59 | 2 | 4992636 | |
| Pubmed | Retinal changes precede visual dysfunction in the complement factor H knockout mouse. | 2.83e-06 | 2 | 59 | 2 | 23844226 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 26374608 | ||
| Pubmed | A gene locus concerned with an antigenic serum substance in Mus musculus. | 2.83e-06 | 2 | 59 | 2 | 4955525 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 2533512 | ||
| Pubmed | Complement factor H: spatial and temporal expression and localization in the eye. | 2.83e-06 | 2 | 59 | 2 | 16936129 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 33558624 | ||
| Pubmed | ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma. | 2.83e-06 | 2 | 59 | 2 | 35167193 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 16998489 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 37940659 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 19620346 | ||
| Pubmed | Copy number variation in the complement factor H-related genes and age-related macular degeneration. | 2.83e-06 | 2 | 59 | 2 | 21850184 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 22136554 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 30705315 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 18824548 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 20694013 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 33859044 | ||
| Pubmed | Regulation of age-related macular degeneration-like pathology by complement factor H. | 2.83e-06 | 2 | 59 | 2 | 25991857 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 24088957 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 20865640 | ||
| Pubmed | A synthetic protein as efficient multitarget regulator against complement over-activation. | 2.83e-06 | 2 | 59 | 2 | 35194132 | |
| Pubmed | Serological survey of complement factor H in common laboratory and wild mice: a new third allotype. | 2.83e-06 | 2 | 59 | 2 | 2522412 | |
| Pubmed | Absence of complement factor H alters bone architecture and dynamics. | 2.83e-06 | 2 | 59 | 2 | 30107932 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23243267 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 34054871 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 17562771 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 27397653 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 34424445 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 29392311 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 1826708 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 22174452 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 22875704 | ||
| Pubmed | Local complement factor H protects kidney endothelial cell structure and function. | 2.83e-06 | 2 | 59 | 2 | 34139209 | |
| Pubmed | Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis. | 2.83e-06 | 2 | 59 | 2 | 32849636 | |
| Pubmed | Complement factor h is critical in the maintenance of retinal perfusion. | 2.83e-06 | 2 | 59 | 2 | 19541934 | |
| Pubmed | Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. | 2.83e-06 | 2 | 59 | 2 | 17921253 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 24664701 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 26149919 | ||
| Pubmed | Murine protein H is comprised of 20 repeating units, 61 amino acids in length. | 2.83e-06 | 2 | 59 | 2 | 2940596 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 32165615 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 24280833 | ||
| Pubmed | Death by color: differential cone loss in the aging mouse retina. | 2.83e-06 | 2 | 59 | 2 | 24929970 | |
| Pubmed | A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome. | 2.83e-06 | 2 | 59 | 2 | 23880784 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 20855886 | ||
| Pubmed | Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis. | 2.83e-06 | 2 | 59 | 2 | 23436934 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 26940089 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23469078 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 15574507 | ||
| Pubmed | Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma. | 2.83e-06 | 2 | 59 | 2 | 23938460 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23133374 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 25532000 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 37032353 | ||
| Pubmed | Location of the mouse complement factor H gene (cfh) by FISH analysis and replication R-banding. | 2.83e-06 | 2 | 59 | 2 | 1486806 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 17517971 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 20445496 | ||
| Pubmed | High-density lipoproteins are a potential therapeutic target for age-related macular degeneration. | 2.83e-06 | 2 | 59 | 2 | 32737203 | |
| Pubmed | CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome. | 2.83e-06 | 2 | 59 | 2 | 36755127 | |
| Interaction | PLSCR3 interactions | 1.02e-05 | 48 | 57 | 4 | int:PLSCR3 | |
| Cytoband | 1q32 | 4.65e-11 | 49 | 59 | 6 | 1q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q31 | 2.79e-06 | 75 | 59 | 4 | chr1q31 | |
| Cytoband | 17q12-q21 | 7.86e-04 | 32 | 59 | 2 | 17q12-q21 | |
| Cytoband | 1p36.21 | 3.02e-03 | 63 | 59 | 2 | 1p36.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 3.24e-03 | 473 | 59 | 4 | chr17q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q22 | 3.81e-03 | 71 | 59 | 2 | chr1q22 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.09e-09 | 57 | 41 | 6 | 1179 | |
| GeneFamily | Complement system|Sushi domain containing | 1.27e-06 | 36 | 41 | 4 | 492 | |
| Coexpression | SU_LIVER | 8.97e-06 | 58 | 59 | 4 | M7054 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-06 | 170 | 59 | 5 | d9ed257d0938442d0bb280e4c4b0c9b657511b46 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.17e-06 | 171 | 59 | 5 | c4a919fe3d56ae6df2fcab6686abacc10befc053 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.55e-06 | 175 | 59 | 5 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.55e-06 | 175 | 59 | 5 | bee8f31f036dfcf9fc6ed29156554771a9ee3c60 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.19e-06 | 181 | 59 | 5 | 3dcb74b28f93be35ddf4de1937f7e30b25e11927 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.19e-06 | 181 | 59 | 5 | 7679a5980011d6dfb1aaca7abf678c29b6f819bb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.53e-06 | 184 | 59 | 5 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.53e-06 | 184 | 59 | 5 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.53e-06 | 184 | 59 | 5 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.04e-06 | 188 | 59 | 5 | a5e7a363fbd5ae4d9312cf6f9941413d6a5c0b4d | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-06 | 194 | 59 | 5 | fb234d97191c95b7880280c6e4ed5df124ffb0e1 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 6.17e-06 | 196 | 59 | 5 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 6.17e-06 | 196 | 59 | 5 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.32e-06 | 197 | 59 | 5 | ea9332adf753d7e92f89654320543abb9e6142aa | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-T_reticular|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.48e-06 | 198 | 59 | 5 | 11f21a4a97da10fc6ae604cb627aa3af749d9dff | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.15e-05 | 123 | 59 | 4 | 64a2d7e40d9c948a9ccaf61c465fb2207e0b7ab8 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue | 4.22e-05 | 146 | 59 | 4 | 1cb2e157222631e8915d89b255a843d16d7d99cc | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.81e-05 | 151 | 59 | 4 | 527059e47e381b2f6d63c1abb39bc0795ee3829d | |
| ToppCell | Frontal_cortex-Endothelial-MURAL|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.81e-05 | 151 | 59 | 4 | 7570372a315bc312ff57bb5f483375c401ae8787 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Ntng1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.65e-05 | 56 | 59 | 3 | ad76712e6a99072f9c6dab6d746db54f754e14fd | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Ntng1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.65e-05 | 56 | 59 | 3 | 20a2977f41d3ecbc4fbee7ecd6dfb4b7ce0e4bb7 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.44e-05 | 169 | 59 | 4 | 0ae65daf092396b71f790b65c7a2feed90397417 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.44e-05 | 169 | 59 | 4 | 8cd70ce27b1cecb83f8a376230e7ef41b079b124 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-05 | 172 | 59 | 4 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-05 | 172 | 59 | 4 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.33e-05 | 174 | 59 | 4 | 912a9e892b29d945666fc37c986009c97c668ac8 | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 8.33e-05 | 174 | 59 | 4 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 179 | 59 | 4 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.29e-05 | 179 | 59 | 4 | 056df2aaff750e0e283e7da78fcc3c90c366aac0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.29e-05 | 179 | 59 | 4 | f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.50e-05 | 180 | 59 | 4 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 9.50e-05 | 180 | 59 | 4 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.50e-05 | 180 | 59 | 4 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.70e-05 | 181 | 59 | 4 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.70e-05 | 181 | 59 | 4 | 65eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(PRG4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.70e-05 | 181 | 59 | 4 | eaac7d58117eddfff06b25521efc431c1351d592 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 1.01e-04 | 183 | 59 | 4 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Late_airway_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 183 | 59 | 4 | 0cea883a8a79fc58abcb26b08bf5db9d3d60f7d4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 185 | 59 | 4 | 5f5df92b328be396941b5812d00454b5ff927d30 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 185 | 59 | 4 | 872720275789d249c9859de825a923803d458875 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 185 | 59 | 4 | 98547c1b1828b76da810ed86082182afaaacdb3f | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 185 | 59 | 4 | e1fbec55b71f604189eb2431768fadbaa0453a83 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 185 | 59 | 4 | 9d933cd5ebc8368fd37aa83113d2dfa6938ff72d | |
| ToppCell | (5)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.08e-04 | 186 | 59 | 4 | acbca8cc048d87faf859b3e77bdb38d0a3dad71c | |
| ToppCell | (5)_Pericytes-(50)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.08e-04 | 186 | 59 | 4 | 67b59defdd1ed3608229cc5e2a3b480d92312afa | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-04 | 186 | 59 | 4 | db4d9ac89cc1e55062ba888b3410b773340595dd | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 186 | 59 | 4 | 55fe25f4d0f2bc0fd4802a0a375169f2c41472fc | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 1.08e-04 | 186 | 59 | 4 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-04 | 187 | 59 | 4 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 1.10e-04 | 187 | 59 | 4 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-04 | 187 | 59 | 4 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 187 | 59 | 4 | 806075c2531a7f5c1da38b85ea494a3b4b5e92ec | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-Late_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.12e-04 | 188 | 59 | 4 | 38a53f99f1876359983936403aefca93281d10fd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-04 | 188 | 59 | 4 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 188 | 59 | 4 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-04 | 188 | 59 | 4 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 188 | 59 | 4 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-04 | 188 | 59 | 4 | b01cb642f8b2d83235706fec7477c15005094161 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 189 | 59 | 4 | a959c9d6a0866582688a4204d625c1e5a123e93d | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 190 | 59 | 4 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.17e-04 | 190 | 59 | 4 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 190 | 59 | 4 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 190 | 59 | 4 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 190 | 59 | 4 | 1ab3f19f1ce9f58e5125135704d94655a2e330a0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 191 | 59 | 4 | 5343a527de6b0f852f45020a91f5b4869e78f13a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 191 | 59 | 4 | a25a5f9a380031fdaf57677a079f97a90f0550c0 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 191 | 59 | 4 | 72f1ddc09080dbfea8d51294cbf7f9d4925f9cc0 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 191 | 59 | 4 | 6e7f589efc997f32175e0789c5ea7ca46e1389b8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-04 | 191 | 59 | 4 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.19e-04 | 191 | 59 | 4 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-neuroendocrine_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 191 | 59 | 4 | 3ce403e0beedb544edeb3ae6eb30267040d00c21 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 192 | 59 | 4 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 192 | 59 | 4 | 43228bddca2f606ddcae9731f04c6b1502c4b85a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 192 | 59 | 4 | f5463c6bcc5c69ac562bec028f7a105c471f2fbe | |
| ToppCell | MatrixFB-Fibroblast-D_(Pericyte)|MatrixFB / shred on cell class and cell subclass (v4) | 1.22e-04 | 192 | 59 | 4 | 630444302511f511ec6976bc045a3b4b9d8d4547 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 192 | 59 | 4 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Club|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 192 | 59 | 4 | 044c7ae56da17cacf2705efa8ac2c8aeba6cfeee | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 192 | 59 | 4 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 192 | 59 | 4 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 192 | 59 | 4 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 192 | 59 | 4 | 88472b99970ba0decbf87164fc241a1c77b3b389 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 192 | 59 | 4 | 20fd69eb60b93d22d9be39de44b733db6d761dde | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 192 | 59 | 4 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 192 | 59 | 4 | 3617d2bc7e33d981f3ec349e9962d8d4bd822fbd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-04 | 193 | 59 | 4 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 193 | 59 | 4 | b9e11cd0896c0868aab7faec4ab7ab4d4e4d1b47 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 193 | 59 | 4 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-04 | 193 | 59 | 4 | a313541cedfcff8fb311b9bc60157359aa103830 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 1.24e-04 | 193 | 59 | 4 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 193 | 59 | 4 | 7766f495f2f945802ef9a5b994cd00bb64d0dfe3 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-04 | 193 | 59 | 4 | 02dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.24e-04 | 193 | 59 | 4 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 193 | 59 | 4 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 194 | 59 | 4 | 7a7406c3b021aeafde423d20290c681c3e8ea0a6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-04 | 194 | 59 | 4 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 194 | 59 | 4 | 3bff2e4eb16719ab7419b2f94c9c6e7302aa6629 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.27e-04 | 194 | 59 | 4 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 194 | 59 | 4 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| ToppCell | 18-Airway-Epithelial-Bud_tip_adjacent|Airway / Age, Tissue, Lineage and Cell class | 1.27e-04 | 194 | 59 | 4 | b45f1e80074a19245bc5dc4b3a583419a1904404 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 194 | 59 | 4 | b8a130ffae68ffe550bf335460a1ec1035cf8d8d | |
| Computational | Genes in the cancer module 58. | 4.25e-07 | 21 | 33 | 4 | MODULE_58 | |
| Computational | Complement. | 6.26e-07 | 23 | 33 | 4 | MODULE_130 | |
| Drug | 1ct8 | 5.15e-06 | 173 | 58 | 6 | CID000444888 | |
| Drug | (2S)-N-[4-(aminomethyl)-1,1-dioxothian-4-yl]-2-[1-(benzenesulfonamido)ethylideneamino]-3-(1-methylcyclopentyl)propanamide | 6.38e-06 | 2 | 58 | 2 | CID011840931 | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; HL60; HG-U133A | 1.11e-05 | 198 | 58 | 6 | 1975_UP | |
| Disease | NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement | 1.08e-11 | 4 | 55 | 4 | EFO_0803292 | |
| Disease | Atypical hemolytic-uremic syndrome | 1.35e-09 | 9 | 55 | 4 | cv:C2931788 | |
| Disease | Hemolytic-uremic syndrome | 1.35e-09 | 9 | 55 | 4 | cv:C0019061 | |
| Disease | Complement deficiency disease | 4.26e-09 | 33 | 55 | 5 | C0272242 | |
| Disease | anaphase-promoting complex subunit 7 measurement | 6.13e-09 | 3 | 55 | 3 | EFO_0801381 | |
| Disease | HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1 | 6.13e-09 | 3 | 55 | 3 | C2749604 | |
| Disease | HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1 | 6.13e-09 | 3 | 55 | 3 | 235400 | |
| Disease | calnexin measurement | 6.13e-09 | 3 | 55 | 3 | EFO_0801444 | |
| Disease | complement factor H-related protein 4A measurement | 6.13e-09 | 3 | 55 | 3 | EFO_0600057 | |
| Disease | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | 6.13e-09 | 3 | 55 | 3 | cv:C2749604 | |
| Disease | histone-lysine N-methyltransferase 2D measurement | 6.13e-09 | 3 | 55 | 3 | EFO_0801683 | |
| Disease | kallikrein-5 measurement | 2.45e-08 | 4 | 55 | 3 | EFO_0020515 | |
| Disease | complement C1s subcomponent measurement | 1.22e-07 | 6 | 55 | 3 | EFO_0008091 | |
| Disease | Age related macular degeneration | 2.86e-07 | 30 | 55 | 4 | C0242383 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 3.41e-07 | 8 | 55 | 3 | DOID:0080301 (is_implicated_in) | |
| Disease | IGA Glomerulonephritis | 4.81e-07 | 34 | 55 | 4 | C0017661 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 5 measurement | 5.11e-07 | 9 | 55 | 3 | EFO_0801766 | |
| Disease | Atypical Hemolytic Uremic Syndrome | 7.29e-07 | 10 | 55 | 3 | C2931788 | |
| Disease | hemopexin measurement | 1.00e-06 | 11 | 55 | 3 | EFO_0008149 | |
| Disease | zinc finger protein 329 measurement | 3.41e-06 | 2 | 55 | 2 | EFO_0803276 | |
| Disease | phosphopantothenoylcysteine decarboxylase measurement | 3.41e-06 | 2 | 55 | 2 | EFO_0802867 | |
| Disease | level of otoraplin in blood serum | 3.41e-06 | 2 | 55 | 2 | OBA_2042720 | |
| Disease | c3d:C3 ratio | 3.41e-06 | 2 | 55 | 2 | EFO_0008543 | |
| Disease | leucine-rich repeat-containing protein 19 measurement | 3.41e-06 | 2 | 55 | 2 | EFO_0801762 | |
| Disease | flap endonuclease 1 measurement | 3.41e-06 | 2 | 55 | 2 | EFO_0802551 | |
| Disease | protein FAM209B measurement | 3.41e-06 | 2 | 55 | 2 | EFO_0802943 | |
| Disease | Age-related macular degeneration | 4.90e-06 | 18 | 55 | 3 | cv:C0242383 | |
| Disease | endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase measurement | 1.02e-05 | 3 | 55 | 2 | EFO_0801568 | |
| Disease | thrombospondin type-1 domain-containing protein 7A measurement | 1.02e-05 | 3 | 55 | 2 | EFO_0803150 | |
| Disease | level of alpha-N-acetylglucosaminidase in blood serum | 1.02e-05 | 3 | 55 | 2 | OBA_2042500 | |
| Disease | soluble transferrin receptor measurement | 1.02e-05 | 3 | 55 | 2 | EFO_0004460 | |
| Disease | age related macular degeneration 1 (is_implicated_in) | 2.04e-05 | 4 | 55 | 2 | DOID:0110014 (is_implicated_in) | |
| Disease | Meningococcal Infections | 2.04e-05 | 4 | 55 | 2 | C0025303 | |
| Disease | Macular Degeneration, Age-Related, 1 | 2.04e-05 | 4 | 55 | 2 | C1864205 | |
| Disease | MACULAR DEGENERATION, AGE-RELATED, 1 | 2.04e-05 | 4 | 55 | 2 | 603075 | |
| Disease | Age related macular degeneration 1 | 2.04e-05 | 4 | 55 | 2 | cv:C1864205 | |
| Disease | complement factor H-related protein 2 measurement | 2.16e-05 | 29 | 55 | 3 | EFO_0600055 | |
| Disease | Membranoproliferative Glomerulonephritis, Type II | 5.09e-05 | 6 | 55 | 2 | C0268743 | |
| Disease | complement factor H measurement | 6.21e-05 | 41 | 55 | 3 | EFO_0008097 | |
| Disease | complement factor H-related protein 5 measurement | 6.68e-05 | 42 | 55 | 3 | EFO_0008098 | |
| Disease | DNA repair protein XRCC4 measurement | 9.48e-05 | 8 | 55 | 2 | EFO_0801532 | |
| Disease | complement factor H-related protein 4 measurement | 1.06e-04 | 49 | 55 | 3 | EFO_0600091 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 1.13e-04 | 50 | 55 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | C3 glomerulopathy | 1.22e-04 | 9 | 55 | 2 | C4087273 | |
| Disease | synaptotagmin-11 measurement | 1.22e-04 | 9 | 55 | 2 | EFO_0802108 | |
| Disease | complement factor H-related protein 1 measurement | 1.58e-04 | 56 | 55 | 3 | EFO_0600054 | |
| Disease | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | 1.94e-04 | 60 | 55 | 3 | EFO_0001365, EFO_0004683, EFO_1001492 | |
| Disease | complement factor H-related protein 3 measurement | 2.82e-04 | 169 | 55 | 4 | EFO_0600056 | |
| Disease | age-related macular degeneration, COVID-19 | 2.94e-04 | 69 | 55 | 3 | EFO_0001365, MONDO_0100096 | |
| Disease | SLAM family member 7 measurement | 4.56e-04 | 17 | 55 | 2 | EFO_0008287 | |
| Disease | Benign neoplasm of stomach | 4.56e-04 | 17 | 55 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 4.56e-04 | 17 | 55 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 4.56e-04 | 17 | 55 | 2 | C0154060 | |
| Disease | mean platelet volume | 5.72e-04 | 1020 | 55 | 8 | EFO_0004584 | |
| Disease | age-related macular degeneration | 6.21e-04 | 89 | 55 | 3 | EFO_0001365 | |
| Disease | coagulation factor measurement | 6.34e-04 | 20 | 55 | 2 | EFO_0004634 | |
| Disease | COVID-19 (is_implicated_in) | 7.00e-04 | 21 | 55 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | Stomach Carcinoma | 7.00e-04 | 21 | 55 | 2 | C0699791 | |
| Disease | Adenoid Cystic Carcinoma | 8.72e-04 | 100 | 55 | 3 | C0010606 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 1.25e-03 | 28 | 55 | 2 | DOID:3717 (is_marker_for) | |
| Disease | Ovarian Carcinoma | 1.44e-03 | 30 | 55 | 2 | C0029925 | |
| Disease | Liver Cirrhosis, Alcoholic | 1.44e-03 | 30 | 55 | 2 | C0023891 | |
| Disease | Breast Cancer, Familial | 1.44e-03 | 30 | 55 | 2 | C0346153 | |
| Disease | chronic lymphocytic leukemia | 1.44e-03 | 119 | 55 | 3 | EFO_0000095 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VQWPCIPDLDSPFLC | 251 | A0A0G2JMD5 | |
| LCGSPCPAVWPDVIK | 951 | Q9NYV4 | |
| ACPHRECIPWQGLLL | 6 | Q3KPI0 | |
| VCGHTGPVLDIDWCP | 76 | Q9ULV4 | |
| QWSEPPKCLHPCVIS | 1156 | P08603 | |
| LPCHCKPEEVPAVVW | 51 | A6NFU0 | |
| RAWGLPCELCPAQPH | 216 | Q75N90 | |
| PKLQWPTPDLCPACH | 526 | Q6ZRP7 | |
| CLPVLDGLLHWAVCP | 2081 | O14497 | |
| PQLQCCRHIVPGPLW | 16 | O95190 | |
| CRHIVPGPLWCSDAP | 21 | O95190 | |
| WLLQCCPSVGPAPGH | 4306 | Q9NU22 | |
| PLPCVHGGSCVDLWT | 611 | Q5IJ48 | |
| LWCPGQPCLPPATCE | 846 | Q5IJ48 | |
| HVPCPPQCACQIRPW | 26 | O75325 | |
| LLCLPAVWGDCGLPP | 26 | P08174 | |
| CVWLECPIPDAPVVT | 911 | P26006 | |
| PGLQPPHCPGQCLIW | 66 | P23409 | |
| CLPSTCPHTVWLLEP | 31 | Q9BYR7 | |
| CLPSTCPHTVWLLEP | 31 | Q9BYR6 | |
| PFHPAPPFDCLWLCL | 1011 | Q7Z3U7 | |
| LPWSPVVCVDHTPKC | 366 | Q02509 | |
| IWEQPPGCPLNTSHL | 691 | Q86VI3 | |
| LPVIAPSCVDVAWPC | 311 | O43316 | |
| PQLPPPCAALWCSGH | 461 | O75173 | |
| CHPNPDLPVWWECGP | 1951 | Q3L8U1 | |
| GEWSEPPRCIHPCII | 256 | Q02985 | |
| PALPGCNVNILCHGW | 141 | Q8N6C5 | |
| KGRWVLITCCAPQPP | 41 | Q6UX52 | |
| YHLPWVLKCGIDPCP | 161 | O95452 | |
| APEPDGCPVCVWRQH | 56 | O95390 | |
| CCEEIQPHQWKPPIE | 896 | Q3T8J9 | |
| CLEDHTWAPPFPICK | 121 | P20851 | |
| WSEPPRCIHPCIITE | 506 | Q92496 | |
| HQIIWPCQPSCVPLD | 111 | P15848 | |
| PLHWQCPYIPLCPLV | 446 | O75064 | |
| TCVLGPTCEGIWPAH | 1176 | Q6ZMW3 | |
| AVTPLPWCPHLVAVC | 1106 | Q9UBN7 | |
| PWCPHLVAVCPIPAA | 1111 | Q9UBN7 | |
| WSEPPKCLHPCVISR | 256 | Q03591 | |
| MIIPDGEWFCPPCQH | 926 | Q96T23 | |
| LPILGWNCLHNLPDC | 171 | Q99500 | |
| QVSSWLCQEPEPCHP | 16 | P12830 | |
| RCPEHPSVPLANCWV | 126 | O15547 | |
| IPHPGCVHGICNEPW | 266 | P78504 | |
| NCIDPWILPHGTCPI | 281 | Q8WVZ7 | |
| PFLLNAVSWLCPCPG | 76 | A6NFQ2 | |
| ILHDVCGIPPFSPQW | 556 | Q7RTY7 | |
| CHLCLPPSEPWDQTL | 336 | Q9UIF7 | |
| PLHWAPCCSLLGPIT | 236 | Q9NQ32 | |
| WLIAPSRACTCVPPH | 16 | P01033 | |
| PPCNCGLVFHLQDPW | 266 | Q96KP6 | |
| WHPATVCKIPPGCNL | 326 | P84022 | |
| GPLWLQGEPLHFCCL | 186 | Q8WZ71 | |
| VQWPCIPDLDSPFLC | 251 | O60809 | |
| PLCREQHASWDPLPC | 721 | Q5HYM0 | |
| PLPHICNWVSANGPC | 511 | Q96F45 | |
| CHIPPVEAERTPWNC | 716 | Q13342 | |
| ACFCPVWPLNLIPLI | 111 | Q8IXB3 | |
| SLPILPQGCVWHPKC | 111 | Q9H6R7 | |
| LQWHPEPPLADCGCT | 2641 | Q9Y493 | |
| CEEWTIAVPGPPHSL | 1031 | P52179 |